OHSU News

This email notification is intended as a heads up to OHSU communicators. It is not shared with external subscribers.

Cancer startup: Drug development company acquires OHSU’s MolecularMD

Cancer startup: Drug development company acquires OHSU’s MolecularMD

By acquiring OHSU's MolecularMD, the clinical research organization ICON, based in Dublin, Ireland, has expanded its laboratory offering in molecular diagnostic testing and brings expanded testing platforms.